Nephrology Dialysis Transplantation · 1995 · 112 citations · 0 references
MedicineInternal MedicineNephrologyDialysisHemodialysisRenal Replacement TherapyBlood Pressure ControlBlood Pressure ManagementChronic Kidney DiseaseHypertensive NephrosclerosisRenal DiseaseAmbulatory Blood Pressure ControlAmbulatory Physiological MonitoringArterial Blood Pressure ControlCardiovascular Outcomes In HemodialysisCardiovascular Risk In Hemodialysis
Abstract High blood pressure (BP) is a major factor contributing to the high incidence of cardiovascular morbidity and mortality in haemodialysis (HD) patients. According to predialysis casual BP measurements, long HD has been shown to provide good BP control. To confirm this result during the period between dialysis sessions, we performed ambulatory monitoring of BP in 91 non-selected HD patients (mean age, 58.7 (14.1) years; 14% incidence of nephrosclerosis and diabetes mellitus; treatment duration, 93.0 (77.2) months; 3×8 h/week, cuprophane, acetate buffer in 95% of the patients). Only one patient (1.1%) was receiving an antihypertensive medication. Ambulatory BP results were systolic (S) BP, 119.4 (19.9) mmHg; diastolic (D) BP, 70.6 (12.9) mmHg; mean (M) BP, 87.6 (13.9) mmHg. These values were significantly lower than the casual predialysis BP data and close to the reference values reported by Staessen et al. in a meta-analysis including 3476 normotensive subjects. The MBP was inversely correlated with the treatment duration, but not with interdialysis weight gain. The MBP increased significantly in the last part of the interdialysis period, and this rise was not correlated with the interdialysis weight gain. The nocturnal/diurnal ratios for SBP and DBP for the HD patients (0.97 and 0.92) were higher than the reference values reported by Staessen, (0.87 and 0.83), and argued against a nocturnal decrease in BP. We found that 52.1% of the patients had an abnormal nocturnal BP fall (MBP fall <5%). This feature worsened during the second night of the interdialysis period. We confirm that interdialysis BP in HD patients treated by long HD and without antihypertensive drugs approached the levels observed in a normal population. Achievement of dry weight is thought to be the cornerstone of this good result, but we cannot rule out other mechanisms such as the optimal clearance of pressor molecules. The BP rise during the interdialysis period, independent of the weight gain, argues for such an accumulation. Despite good BP control the circadian rhythm of BP is not restored in our patients, and remains to be studied.